Promising GLP-1 Drugs for Parkinson’s and Alzheimer’s
Reading Time: 3 minutes
Introduction
In recent years, a class of diabetes drugs, known as GLP-1 receptor agonists, has shown significant potential in treating not just diabetes but also neurodegenerative conditions like Parkinson’s disease (PD) …
Read MoreHearing Aids Delay Parkinson’s
Reading Time: 3 minutes
Introduction
Recent research has uncovered an unexpected link between hearing aids and a reduced risk of Parkinson’s disease (PD). A landmark study involving millions of U.S. veterans shows that hearing aids …
Read MoreContinuous Infusion Therapy for Parkinson’s: A New Solution
Reading Time: 3 minutes
Introduction
Managing motor fluctuations in advanced Parkinson’s disease (PD) is an ongoing challenge, particularly as oral medications lose efficacy over time. The recent approval of Vyalev by the FDA offers new …
Read MoreTechnology Transforms Parkinson’s Management
Reading Time: 4 minutes
In recent years, technology has revolutionized the way we manage Parkinson’s disease (PD), providing patients with tools that offer better monitoring, treatment, and symptom control. By utilizing advanced, non-invasive technology …
Delivering the GAD Gene Directly into Targeted Brain Cells
Reading Time: 5 minutes
One of the most remarkable aspects of AAV-GAD therapy is its precision. The therapy is designed to deliver the GAD gene directly into specific areas of the brain that are …
Read More